More than 40,000 people in the United States are living with cystic fibrosis, a genetic disease that affects the mucous membranes in the body.

Clinical trials for idiopathic pulmonary fibrosis could benefit from improved patient engagement to include diverse ...

Kaminski and his colleagues were pioneers in applying high-throughput, genome-scale transcript profiling to advanced lung ...

A combination treatment may improve survival in patients with both pulmonary hypertension and pulmonary fibrosis, a study ...

An EU committee is recommending that tranilast, the active ingredient in a pulmonary fibrosis drug candidate, be awarded ...

Discover how rare genetic variants and common polygenic risk scores independently influence survival in idiopathic pulmonary ...

Gyre anticipates revenue growth over the remainder of the year, driven by the planned commercial launch of Nintedanib in May 2025 and the continued expansion of avatrombopag. Based on current ...

About two-thirds of the staff that provides free examinations for the deadly disease, which one study says affects 1 in 5 ...

The incidence of infection by Mycobacterium abscessus is increasing in patients with cystic fibrosis, chronic obstructive ...

The incidence of infection by Mycobacterium abscessus, is increasing in patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), and other chronic pulmonary diseases, leading to an ...

Many will gather at Elm Street Urban Park in Bethesda to join the 5K walk to raise awareness on finding a cure for cystic ...

On April 12th, the Wolcott Community Park was full of hope, laughter, and support from the surrounding community members all ...